Mereo BioPharma Group Plc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Mereo BioPharma Group Plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Mereo BioPharma Group Plc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Mereo BioPharma Group Plc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Mereo BioPharma Group Plc is MREO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Mereo BioPharma Group Plc has its primary listing on NASDAQ. You can trade Mereo BioPharma Group Plc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Mereo BioPharma Group Plc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Mereo BioPharma Group Plc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Mereo BioPharma Group Plc.